March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
From Innovation Ecosystem to Industrial Base
Commentary
Introduction America’s defense technology boom is real. Venture-backed firms building in artificial intelligence (AI), autonomy, space, and advanced manufacturing are winning ...
By Brian Katz
-
Podcast
Defense / Technology & National Security
WarTalk: Iran War with Jack ShanahanThe “love tap” White House readout. A failed convoy operation. KSA pulling overflight rights. Iran with 70% of its missile force still intact. And one F-15E shoot-down from ab...
By Lt. Gen. Jack Shanahan & Jordan Schneider
-
Numbers Matter
Podcast
Among the many lessons of Ukraine and the Iran war is the role of small, distributed air and missile defenses, whether using — or defending against — missiles or drones. Dr. S...
By Stacie Pettyjohn
-
Experts Make Their Picks for Acquisition Reform Litmus Tests
Commentary
If the department cannot pass these easy tests, there is little reason to believe it will do well on the harder ones....
By Stacie Pettyjohn
